⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Compassionate useThyroid Analog

Compound 61457

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061457
Risk Class
MODERATE
Last Audit
Feb 18, 2108

Research Abstract

Thyroid Analog candidate engineered for endocrine support initiatives with automated dossier coverage.

Compound 61457 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for endocrine support and performance longevity.

The dossier currently sits in compassionate use with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.

Supply records cite CAS AUTO-061457 with updates logged 2108-02-18.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Endocrine supportPerformance longevity

Nomenclature

CX-61457Thyroid Analog Program 61457

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061457
  2. [2] Operations Pulse • Thyroid Analog innovation track
  3. [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61457